ARETEIA THERAPEUTICS, INC.

Profile

Company Names

ARETEIA THERAPEUTICS, INC.

Addresses

101 GLEN LENNOX DR., SUITE 300, CHAPEL HILL, NC 27517

1200 MORRIS TURNPIKE, SUITE 3005, SHORT HILLS, NJ 07078

Phone Numbers

212-993-3113
617-504-0362

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2022

State Incorporated:

DELAWARE

Total Amount Raised:

$360,000,020.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2022-06-15 
$360,000,020.00 
$445,000,000.00 
$84,999,980.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JORGE 
 
BARTOLOME 
EXECUTIVE OFFICER, DIRECTOR
ARETEIA THERAPEUTICS, INC.
DANIEL 
 
BECKER 
DIRECTOR
WATCHWITH, INC.   |  NEURANA PHARMACEUTICALS, INC.   |  PRINCIPIA BIOPHARMA INC.   |  PANDION THERAPEUTICS HOLDCO LLC   |  DTX PHARMA, INC.   |  DAY ONE BIOPHARMACEUTICALS HOLDING CO LLC   |  MATCHPOINT THERAPEUTICS INC.   |  ARETEIA THERAPEUTICS, INC.
WHIT 
 
BERNARD 
EXECUTIVE OFFICER
ARETEIA THERAPEUTICS, INC.
PAUL 
 
BERNS 
DIRECTOR
ANACOR PHARMACEUTICALS, INC.   |  CELLECTAR BIOSCIENCES, INC.   |  UNITY BIOTECHNOLOGY, INC.   |  ARCH VENTURE FUND XII, L.P.   |  ELEPHAS BIOSCIENCES CORP   |  ARETEIA THERAPEUTICS, INC.   |  NEUMORA THERAPEUTICS, INC.   |  MIRADOR THERAPEUTICS, INC.   |  OLLIN BIOSCIENCES, INC.
MICHAEL 
E. 
BOZIK 
DIRECTOR
KNOPP NEUROSCIENCES INC   |  KNOPP NEUROSCIENCES INC.   |  KNOPP BIOSCIENCES LLC   |  ARETEIA THERAPEUTICS, INC.
STEPHEN 
 
BUTTS 
DIRECTOR
NEURONEX, INC.   |  SOLAS PHARMA, LLC   |  AERIAL BIOPHARMA, LLC   |  ARETEIA THERAPEUTICS, INC.
CHRISTOPHER 
 
COURTS 
EXECUTIVE OFFICER
ARETEIA THERAPEUTICS, INC.
CHRISTOPHER 
TODD 
COX 
EXECUTIVE OFFICER
ARETEIA THERAPEUTICS, INC.
BENJAMIN 
 
GOMEZ 
DIRECTOR
ARETEIA THERAPEUTICS, INC.
ADAM 
 
KOPPEL 
DIRECTOR
BROOKSIDE II CAYMAN LTD   |  BROOKSIDE CAPITAL PARTNERS FUND II, L.P.   |  BROOKSIDE CAPITAL PARTNERS FUND LP   |  BROOKSIDE CAYMAN LTD   |  BROOKSIDE CAYMAN PA LTD   |  PTC THERAPEUTICS, INC.   |  VIACYTE INC.   |  SOLID BIOSCIENCES INC.   |  CARDURION PHARMACEUTICALS, INC.   |  ARETEIA THERAPEUTICS, INC.
IAN 
 
READ 
DIRECTOR
ARETEIA THERAPEUTICS, INC.   |  EMPERY DIGITAL, INC.
ELYSE 
 
STOCK 
DIRECTOR
ARETEIA THERAPEUTICS, INC.
CHRIS 
 
VISIOLI 
EXECUTIVE OFFICER
ARETEIA THERAPEUTICS, INC.
ROBIN 
 
WALKER 
EXECUTIVE OFFICER
ARETEIA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-02-21
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-06-15 
2024-02-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-06-15 
2022-07-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-06-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
COWEN AND COMPANY, LLC
7616